Last update 06 Nov 2024

EV-077

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
EV 077, EV-077-3201-2, EV-077-3201-2TB
+ [7]
Mechanism
TBXA1R antagonists(thromboxane A1 receptor antagonists), TBXA2R antagonists(Thromboxane A2 receptor antagonists), TXA2 synthase inhibitors(Thromboxane A2 synthase inhibitors)
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC22H23ClO5
InChIKeyWHUIENZXNGAHQI-GKZDNZBASA-N
CAS Registry1041850-31-0

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AlbuminuriaPhase 3
AU
18 Aug 2021
AlbuminuriaPhase 3
NZ
18 Aug 2021
Diabetes Mellitus, Type 2Phase 3
AU
18 Aug 2021
Diabetes Mellitus, Type 2Phase 3
NZ
18 Aug 2021
Diabetic NephropathiesPhase 3
AU
18 Aug 2021
Diabetic NephropathiesPhase 3
NZ
18 Aug 2021
Diabetes Mellitus, Noninsulin-Dependent, 2Phase 2
DE
01 Jan 2012
stress oxidativePhase 2
DE
01 Jan 2012
VasculitisPhase 2
DE
01 Jan 2012
Influenza A virus infectionPreclinical
CH
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free